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The reason why vulnerabilities tomutant polyglutamine (polyQ) proteins are different among neuronal subtypes ismostly unknown. In
this study, we compared the gene expression profiles of three types of primary neurons expressing huntingtin (htt) or ataxin-1.We found
that heat shock protein 70 (hsp70), a well known chaperone molecule protecting neurons in the polyQ pathology, was dramatically
upregulated only bymutant htt and selectively in the granule cells of the cerebellum. Granule cells, which are insensitive to degeneration
in the human Huntington’s disease (HD) pathology, lost their resistance by suppressing hsp70 with siRNA, whereas cortical neurons,
affected in human HD, gained resistance by overexpressing hsp70. This indicates that induction levels of hsp70 are a critical factor for
determining vulnerabilities to mutant htt among neuronal subtypes. CAT (chloramphenicol acetyltransferase) assays showed that CBF
(CCAAT box binding factor, CCAAT/enhancer binding protein ) activated, but p53 repressed transcription of the hsp70 gene in granule
cells. Basal andmutant htt-induced expression levels of p53 were remarkably lower in granule cells than in cortical neurons, suggesting
that different magnitudes of p53 are linked to distinct induction levels of hsp70. Surprisingly, however, heat shock factor 1 was not
activated in granule cells by mutant htt. Collectively, different levels of hsp70 among neuronal subtypes might be involved in selective
neuronal death in the HD pathology.
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Introduction
Susceptibilities to neurodegeneration are different among neuro-
nal subtypes. Neuron subtype-specific cell death (selective neu-
ronal death) remains one of the unsolved questions in the re-
search of neurodegenerative disorders. One typical case of
neuron subtype-specific cell death is amyotrophic lateral sclerosis
in which lower and uppermotor neurons are exclusively affected.
Selective neuronal death is more or less observed in most human
neurodegenerative diseases. For instance, striatal neurons and
cortical neurons are severely affected in Huntington’s disease,
although granule cells in the cerebellum are preserved except in
rare cases of homozygote or extremely long polyglutamine
(polyQ) expansion. In spinocerebellar atrophies, however, stria-
tal and cortical neurons are basically preserved. Because selective
neuronal death is a critical feature of neurodegenerative disor-
ders, elucidation of its underlying mechanisms is indispensable
for our understanding of neurodegeneration.
Several hypotheses have been proposed to explain selective
neuronal death. For instance, in the HD pathology, some re-
searchers have proposed that aggregation-prone short peptides
are selectively cleaved out of full-length proteins in striatal neu-
rons (Li et al., 2000). In addition, regarding the HD pathology,
phosphorylation of Ser421 is significantly reduced in the striatum
in vivo (Warby et al., 2005). The phosphorylation of huntingtin at
Ser421, which is mediated by Akt and stimulated by IGF-1 or
FK506 (Humbert et al., 2002; Pardo et al., 2006), leads to reduc-
tion of the toxicity (Humbert et al., 2002; Colin et al., 2005;
Warby et al., 2005). In the pathology of spinocerebellar ataxia
type-1, several nuclear proteins such as LANP (leucine-rich
acidic nuclear protein) and PQBP1 (polyglutamine tract binding
protein 1) expressed in specific types of neuron have been impli-
cated (Matilla et al., 1997;Okazawa et al., 2002). It is important to
note that all the mechanisms proposed thus far provide explana-
tions for the acceleration of neuronal dysfunction and/or cell
death in specific neurons. The converse idea that a protective
mechanism might function in specific neurons to make them
resistant to the polyQ pathology, however, has not been tested.
An obvious approach to investigate the molecular mecha-
nisms underlying the above-mentioned selective vulnerability
would be to isolate the binding factors of the disease protein that
are expressed in specific neuronal subtypes. This approach has
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actually succeeded in discovering several possible candidates
(Matilla et al., 1997; Humbert and Saudou, 2002; Okazawa,
2003). Another approach would be to screen neuronal subtype-
specific changes in transcriptome, proteasome, andmetabolome.
In this study, we performed a microarray analysis to analyze the
difference in gene expression profiles of different neuronal sub-
types under mutant polyQ protein expression.
We found that heat shock protein 70 (hsp70), a well known
chaperone molecule that protects neurons against mutant polyQ
proteins (Cummings et al., 1998, 2001; Warrick et al., 1999; Chai
et al., 1999; Zhou et al., 2001; Adachi et al., 2003; Wacker et al.,
2004), is selectively upregulated by mutant htt in granule cells
resistant to HD. Furthermore, as a mechanism for the cell-
specific regulation of hsp70, we found that p53 represses tran-
scriptional upregulation of hsp70 in vulnerable neurons like cor-
tical neurons, but not in resistant neurons like cerebellar granule
cells. This novel mechanism for neuron subtype-specific pathol-
ogy may be useful for obtaining a better understanding selective
neuronal death in neurodegeneration.
Materials andMethods
The preparation of RNA and cDNA. Total RNA was extracted from the
cells and tissues with a Trizol reagent (Invitrogen, Carlsbad, CA). The
synthesis of cDNA by reverse transcription was performed using an LA
PCR kit version 2.1 (Takara, Tokyo, Japan) and an oligo-dT primer.
Microarray analysis. The total RNAs were labeled and hybridized with
DNAmicroarrays according to themanufacturer’s protocol. To start, the
cDNAs synthesized from 10 g of the total RNA were labeled with cya-
nine 3 (Cy3) or Cy5 using a fluorescence direct label kit (Agilent Tech-
nologies, Palo Alto, CA). Rat DNA microarrays, on which the cDNAs
(mean length of 500 bases) of 14,811 genes were spotted, were hybridized
with Cy3- and Cy5-labeled cDNAs at 65°C for 17 h. The gene chips were
then washed with 0.5 SSC/0.01% SDS and 0.06 SSC at room temper-
ature, dried, and scanned by a microarray scanner, CRBIOIIe (Hitachi,
Tokyo, Japan). Data analyses were performed using DNASIS Array (Hi-
tachi). After control spots and artifact signals were excluded, the signal
intensity of a spot was calculated as the ratio of the total intensity of a
given gene chip. Standardized signal intensities were scatter-plotted with
Cy3 fluorescence on the y-axis and Cy5 fluorescence on the x-axis. We se-
lected genes whose Cy3/Cy5 ratios were3.0 or0.33 for further analyses.
The primary culture of neurons. Primary neurons were prepared from
the cerebral cortex or the striatum of 17-d-old Wistar rat embryos. Cer-
ebellar neurons were prepared from Wistar rat pups at postnatal day 7
(SLC, Shizuoka, Japan). The rats were put under deep anesthesia with
ether. Their brains were then dissected, minced into fine pieces, and
rinsed with PBS. After incubation with 0.25% trypsin at 37°C for 20min,
the pieces were gently triturated with blue tips and filtered through a
nylon mesh (Falcon 2350; Becton Dickinson, Bedford, MA) to remove
any debris. Cells were then washed twice with culture medium contain-
ing 10% fetal bovine serum. For cortical and striatal neurons, DMEM
(Nissui, Tokyo, Japan) containing 25 mM D-glucose, 4 mM L-glutamine,
and 25 g/ml gentamycin, was used. In addition, 25 mM KCl containing
the above culture medium was used for the cerebellar granule neurons.
Cells were seeded into dishes (Corning, Corning, NY) coated with poly-
L-lysine (Sigma, St. Louis, MO) at 1.8  105 cells/cm2, and cultured at
37°C and 5%CO2. To remove proliferating glial cells, arabinosylcytosine
(Sigma) was added to the culture medium (4 M) on the following day.
HeLa cell culture. HeLa cells were maintained in DMEM (Sigma),
which contained 10% fetal bovine serum (ICN Pharmaceuticals, Costa
Mesa, CA), 100 U/ml penicillin (Invitrogen), and 100 g/ml streptomy-
cin (Invitrogen) in 5% CO2 at 37°C.
Plasmid and cosmid construction. Rat cDNAs of hsp70,Cbl-b,Omi, p53,
and CCAAT box binding factor (CBF ) were isolated with reverse tran-
scriptase PCR cloning. Hsp70, Omi, and Cbl-b cDNAs were amplified
with the following primers: hsp70F (5-CATGGCCAAGAAAACAGC-
3) and hsp70R (5-CTAATCCACCTCCTCGATG-3), OmiF (5-GAG-
CCGAGGCGGAGCAG-3) and OmiR (5-TCAAACCCTTGCCAATC-
CAG-3), or Cbl-bF (5-CCGCTCGAGACGAAAGGACTAAGATT-
CCAG-3) and Cbl-bR (5-CCCAAGCTTCTATAGATTGAGACGTG-
GCG-3) from cDNA of whole rat cerebellum, and subcloned into the
StuI site of pCR-Blunt (Invitrogen). The cDNAs of hsp70 and Omi were
then digested with EcoRI from the Hsp70/pCR-Blunt and Omi/pCR-
Blunt. cDNA of Cbl-b was cloned into the XhoI and HindIII sites of
pBluescript I SK (Toyobo, Osaka, Japan). The inserts were subse-
quently cleaved out with EcoRI or XhoI-HindIII, respectively. They were
then subcloned in the SwaI site of the pAxCAwt cosmid (Takara) after
blunting of the inserts with a Blunting High kit (Toyobo). The p53 gene
was amplified with primers p53F (5-GGAATTCCATGGAGGATT-
CACAGTCGG-3) and p53R (5- ACGCGTCGACTCAGTCTGAGTC-
AGGCCCC-3) from the cDNAof rat cerebellumprimary neurons. They
were subcloned into the EcoRI and SalI sites of pBluescript II SK and
then digested with EcoRI-SalI and recloned into the EcoRI and SalI sites
of pCIneo. The CBF gene likewise was amplified with primers CBFF (5-
ACGCGTCGACAATGTCGGCGGACCAGGAA-3) and CBFR (5- AT-
AAGAATGCGGCCGCTCACTTCCTTTGTCTTTTGGG-3) from the
cDNA of rat cerebellum primary neurons, and then cloned into the SalI
and NotI sites of pBluescript II SK. To construct expression vectors of
Cbl-b with a FLAG sequence at the N terminus, blunted NheI and NotI
fragments of CBF were subcloned into the SalI and NotI sites of pCIFm,
which contained a FLAG sequence at theNotI site of pCIneo (Stratagene,
La Jolla, CA). The plasmids were designated pCI-FLAG-Cbl2 and pCI-
FLAG-CBF, respectively.
Adenovirus. The cosmid of rat hsp70-, Cbl-b-, and Omi-pAxCA, were
transfected into 293 cells through the calcium-phosphate method using
the digested DNA of adenoviruses. After the cells expired, the medium
was recovered as the virus solution. We then rechecked the construction
of the adenovirus vectors through PCR and confirmed that the E1A
protein was deleted and that the insert was maintained correctly. After
the check, we amplified the adenoviruses two to three times. We desig-
nated the adenovirus vectors as AxCA-Hsp70, AxCA-Cbl-b, and AxCA-
Omi. The vectors were used to infect HeLa cells and primary neurons at
a multiplicity of infection of 300 and 100, respectively. Adenovirus,
AxCA-htt(exon1)20Q, -htt(exon1)111Q, -Atx30Q, and -Atx82Q, were
constructed as described previously (Hoshino et al., 2003, 2004; Tagawa
et al., 2004). The adenovirus vectors contain the htt exon-1 peptide or the
full-length ataxin-1 (Atx-1) protein.
Western blotting analysis of cells and human brains. For Western blot
sampling, whole cells were dissolved in 62.5 mM Tris/HCl, pH 6.8, 2%
(w/v) SDS, 2.5% (v/v) 2-mercaptoethanol, 5% (v/v) glycerin, and
0.0025% (w/v) bromophenol blue on culture dishes. The cell lysates were
collected from six-well dishes containing 3.3 104 cells/well (HeLa and
293 cells) and wells containing 1.0 105 primary neurons/well. Human
brain samples were prepared from sixHuntington’s disease patients con-
firmed by CAG repeat expansion (grade 1–5; 43- to 60-year-old) and
from six nonfamilial Parkinson’s disease (PD) patients (Yahr’s stage 1–5;
46- to 73-year-old). Brains of the age-matched non-neurological disease
patients were used as the control. In these cases, 1-mm-thick tissues were
carefully prepared under the microscope from the brain surface of the
prefrontal cortex or cerebellar hemisphere cortex of these patients and
used for the analysis. Brain samples of mutant htt-transgenic R6/2 mice
(Mangiarini et al., 1996), B6CBA-Tg(HDexon1)62Gpb/1J (The Jackson
Laboratory, Bar Harbor, ME), were prepared similarly at the age of 4 or
14 weeks. These samples were separated by SDS-PAGE, transferred onto
polyvinilydene difluoride membrane Fine Traps (Nihon Eido, Tokyo,
Japan) through a semidry method, blocked by 5% milk in TBS with
Tween 20 (TBST) (10 mM Tris/Cl, pH 8.0, 150 mM NaCl, 0.05% Tween
20), and incubated with appropriate antibodies as described previously
(Tagawa et al., 2005). The filters were incubated with each primary anti-
body for 2 h, with the corresponding horseradish peroxidase (HRP)-
conjugated second antibody at a 1:3000 dilution for 1 h at room temper-
ature in5%milk/TBST.Finally, the targetmoleculeswerevisualized through
an enhanced chemiluminescenceWesternblottingdetection system(Amer-
sham Biosciences, GEHealth Care Biosciences, Hong Kong).
Immunocytochemistry. The cells were fixed in 1% paraformaldehyde/
0.1 MPBS, pH7.4, for 30min, and permeabilizedwith 0.1%TritonX-100
in PBS for 5 min at room temperature. Subsequently, the cells were
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washed with PBS, blocked with 0.5% milk in PBS for 30 min at room
temperature, and incubated with primary antibodies in PBS containing
0.5% milk for 2 h at room temperature. Anti-polyQ antibody CAG53b
was diluted at a ratio of 1:10,000 and anti-hsp70 antibody (K20, Santa
Cruz Biotechnology, Santa Cruz, CA) was diluted to 1:100. Incubation
with the secondary antibodies, Alexa Fluor 350, 488, and 588- labeled
anti-IgGs (Invitrogen), diluted at 1:1000 in 0.5% milk in PBS, was per-
formed for 30 min at room temperature. We calculated their signal in-
tensities per area as described previously (Hoshino et al., 2003).
The immunohistochemistry of human brain tissues. Postmortem brain
tissues were prepared from three HD patients confirmed by CAG repeat
expansion and one from disease control. The paraffin-embedded sec-
tions were deparaffinized, rehydrated, and then autoclaved in 10 mM of
citrate buffer, pH 6.0, at 120°C for 15min. These sections were incubated
sequentially with 3%hydrogen peroxide for 20min at room temperature
to inhibit endogenous peroxidase, then with 1.5% normal goat serum in
PBS for 30 min at room temperature, followed by incubation with pri-
mary antibodies against hsp70 (K20) for overnight at 4°C, and finally
with Envision anti-rabbit or -mouse (Dako, High Wycombe, UK) for
3 h at room temperature. The anti-hsp70 antibody was used at a 1:200
dilution, washed with 0.1% Tween 20–TBS (TNT) buffer twice, and
incubated with an HRP-conjugated secondary antibody (1:3000; GE
Healthcare) for 1 h at room temperature (RT). The antibodies were then
washed again with TNT buffer twice, and visualized through incubation
with FITC tyramide (1:200; Perkin-Elmer, Boston, MA) for 10 min. The
tyramide complex was stripped through incubation with 0.05 M glycine-
HCl at pH 3.6 for 3 h at RT.
RNA interference. The cells were transfected with siRNA oligonucleo-
tides using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions. A total of 2.5  104 cells in six-well dishes were
infected with 0.5 g siRNA/well, 24 h after plating. The siRNAs corre-
sponding to hsp70 mRNA were designed with two base overhangs
(dTdT) on each strand, and chemically synthesized by Qiagen (Hilden,
Germany). The targeted sequences were Hsp70-siRNA#1 (5-
AAGGTGCAGGTGAACTACAAG-3) and Hsp70-siRNA#2 (5-
AACACGCTGGCTGAGAAAGAG-3). A verified siRNA against CBF
was purchased from Qiagen (Mm Cebpz 1 HP siRNA, SI00948451).
Cell death assays (trypan blue staining). The cells were incubated for 5
min in a solution of 0.4% trypan blue (Invitrogen). In each experiment,
blue stained (nonviable) and nonstained (viable) cells were counted in
10–20 visual fields, randomly selected at 100magnification from each
of three dishes. We counted at least 1000 cells for each condition.
Cell fractionation. The cells were harvested by scraping, collected in PBS,
and then centrifuged for 4min at 480 g and 4C. The pellet was suspended in
eight volumes of lysis buffer (20mMHEPES, pH 7.9, 1mMEDTA, pH 8.0, 1
mM dithiothreitol, 10% glycerol, 0.5 mM spermidine, 1 mM phenylmethyl-
sulfonyl fluoride, 1 g/ml pepstatin A, 0.3 g/ml antipain, and 1 g/ml
leupeptin), to which NP-40 was added, making a final concentration of
0.3%, thenhomogenizedby10strokesof aDouncehomogenizer typeB.The
separated nuclei in the homogenate were checkedmicroscopically. The ho-
mogenate was centrifuged at 11,100 g at 4°C, for 10 min. The pellet and
supernatant were nuclear and cytosolic fractions, respectively.
CAT (chrolamphenicol acetyltransferase) assay. To construct reporter
plasmids, the human hsp70 promoter region (198bp), was amplified by
using the following primers: hHsp70proF (5-CCGCTCGAGGAAG
AGTCTGGAGAGTTCTG-3) and hHsp70proR (5-CCCAAGCTT-
CCGGA CCCGTTGCCCCT-3) from human genomic DNA (G1471,
male; Promega, Madison,WI), and subcloned into the XhoI andHindIII
sites of p0CAT. The resultant plasmid was designated as hHsp70pro. The
deletion plasmids of the proximal or distal CCAAT elements were con-
structed by PCR with the following primers: Hsp70pro-dproCCAAT-F
(5-CTCAGAAGGGAAAAGGCGG-3) and Hsp70pro-dproCCAAT-R
(5-ACCGAGCTCGATGAGGCTG-3), or Hsp70pro-ddisCCAAT-F (5-
TCCAAGGAAGGCTGGGGG-3) and Hsp70pro-ddisCCAAT-R (5-
AGAGGCCAGAGTGCCGCC-3), from Hsp70pro/p0CAT. The deletion
plasmid of both CCAAT elements was constructed with the primers,
hHsp70proF andhHsp70proR, fromhHsp70pro-ddisCCAAT/p0CAT.Ten
micrograms of reporter and effector plasmids were transfected into 1 106
HeLa cells and neurons using a Superfect reagent (Qiagen) or a Lipo-
fectamine Plus reagent (Invitrogen) according to commercial protocol.
Forty-eight hours after transfection, cells were harvested with 0.25 M Tris-
HCl, pH 7.5, andCAT assays were performed as described previously (Oka-
moto et al., 1990; Okazawa et al., 1991).
ChIP assay. A ChIP assay was performed according to the method
described previously (Shang et al., 2000), with onlyminormodifications.
Because no antibody was available for detecting CBF, the primary cere-
bellar neurons were transfected using the pCI-FLAG-CBF with Lipo-
fectamine 2000 (Invitrogen). After 2 d, formaldehyde was added directly
to the culturemediumof the primary neurons for a final concentration of
1% to cross-link DNA and nuclear proteins. The medium was then in-
cubated for 10 min at room temperature. After terminating the cross-
linking with glycine, the cells were washed extensively and harvested in
the presence of protease inhibitors. Nuclei were then separated and chro-
matin was sonicated to 600 bp fragments. After a preclearance with a
salmon sperm DNA/protein agarose slurry, anti-FLAG M2 monoclonal
antibody (Sigma)was used at a 1:500 dilution and incubated overnight at
4°C for immunoprecipitation of the DNA-protein complex. Anti-p53
antibody (R-19; SantaCruzBiotechnology)was similarly used at a 1:1000
dilution. After standard washing and elusion procedures, cross-linking
was reversed by incubation with RNase in 0.3 MNaCl for 5 h at 65°C. The
DNA was then precipitated using a 0.5 vol of ethanol treated with 4
mg/ml proteinase K, purified with QiaQuick spin columns (Qiagen),
and used as a template for PCR. The primers 5-TACCTCATCATGTT-
TGGTGC-3 and 5-CGTTTGGCTTGCTAGGCAAG-3were used to am-
plify 280 bp surrounding the CCAAT box at287 of the rat hsp70 gene.
Results
Integrative analyses of gene expression profiles suggest
multiple candidate genes
To explore the molecular mechanisms underlying the selective
pathology of polyQ diseases (i.e., distinct susceptibilities of dif-
ferent neurons to different polyQ proteins), we performed DNA
microarray analyses with three types of primary neurons (corti-
cal, striatal, and cerebellar neurons) expressing either htt or
Atx-1, and compared the expression profiles of 14,000 genes
among them. Our reasons for using primary neurons instead of
human or mouse brain tissues are as follows: (1) to exclude the
contamination of glial or vascular cells from the analysis, (2) to
detect early changes in gene expression (i.e., expression profiles at
the starting point of aggregate formation), and (3) to compare
easily multiple combinations of disease genes and neuron sub-
types. Before starting the microarray analysis, we checked the
expression levels of two polyQ genes in three types of neurons
(supplemental Figs. 1, 2, available at www.jneurosci.org as sup-
plemental material) and confirmed the expression levels of a
polyQ protein to be almost equivalent in three subtypes of neu-
rons and the expression levels of different polyQ proteins to be
almost equivalent in a subtype of neurons.
To delineate changes in gene expression thatmight be relevant
to the selective neuronal death or dysfunction, we compared the
gene expression profiles of multiple neuronal subtypes under
mutant and normal polyQ protein expression by adenovirus vec-
tors at 2 d after infection, when only a very few neurons show
inclusion bodies (Tagawa et al., 2004). The expression efficiencies
of htt and Atx-1 proteins by adenovirus vectors in primary neu-
rons have been examined previously (Tagawa et al., 2004;
Hoshino et al., 2003, 2004). As described in those methods, the
E1A protein was deleted in our adenovirus vectors to prevent
viral proliferation. The viruses can proliferate in only 293 cells
stably expressing the E1A protein. The expression of mutant htt
by the adenovirus vector induces cell death in a small percentage
of neurons by 4 d of infection (Tagawa et al., 2004). Therefore,
RNA samples prepared on day 2, when cell death is not yet de-
tectable (Tagawa et al., 2004), were used in microarray analyses,
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to prevent the detection of secondary changes by cell death.Using
this protocol, we infected three types of primary neuronswith the
adenovirus vectors of the full-length protein of Atx-1 or the htt
exon-1 peptide (Tagawa et al., 2004) and prepared mRNA.
Six setsof analyseswereconductedusing twopolyQdiseasegenes
and three types of primary neurons (Fig. 1A). In each set, we com-
pared the gene expression profiles undermutant polyQ and normal
polyQ expression two times. We then selected genes whose expres-
sion was changed more than threefold (Fig. 1, supplemental Tables
1, 2, available atwww.jneurosci.org as supplementalmaterial).Next,
we compared the changed genes among different sets in terms of
neuron-type, disease gene, and susceptibility of neurons, to select
candidate genes that might be relevant to the pathology (Fig. 1B).
The first notable observation from the com-
parisonwas that therewasnooverlapamong
the groups except in the case of one gene up-
regulated by the expression of mutant htt in
cerebellar neurons, and by Atx-1 in striatal
neurons (Fig. 1B, bottom right). This gene,
heterogeneous nuclear ribonucleoproteinH
(hnRNPH), has been identified as a compo-
nent of htt aggregates previously (Hazeki et
al., 2002), although its implication in the pa-
thology has not been clarified in detail.
From the comparison, we selected the
following candidate genes that were
changed selectively in the vulnerable neu-
rons or in the resistant neurons. Omi/
HtrA2 and Cbl-b/Cbl-2 were downregu-
lated by mutant htt selectively in the
striatal neurons that are most vulnerable
to HD. Hsp70, however, was upregulated
by mutant htt in cerebellar neurons not
affected by HD. Although some of these
genes may be involved in the disease’s pa-
thology (R. Inagaki,M.-L. Qi, andH.Oka-
zawa, unpublished observation), we focus
only on hsp70 in this paper.
Mutant htt but not mutant Atx-1
induces the upregulation of hsp70
specifically in cerebellar neurons
hsp70 was outstanding regarding the ex-
tent of change of gene expression. In pri-
mary cerebellar neurons (most of them are
granule cells) expressingmutant htt, hsp70
was upregulated to a magnitude of 30-
fold. Interestingly, the change was consid-
ered specific because hsp70was not altered
in primary striatal or cortical neurons, and
because Atx-1 did not affect hsp70 in cere-
bellar neurons (Fig. 1, supplemental Ta-
bles 1, 2, available at www.jneurosci.org as
supplemental material). In addition, ade-
novirus vectors expressing polyQ genes
lacked the E1A protein. The upregulation
of hsp70 was not observed in adenovirus-
infected neurons other than htt-
expressing cerebellar neurons (Fig. 1A).
Therefore, although the E1A virus protein
could induce hsp70 (Kao et al., 1985;Wu et
al., 1986; Williams et al., 1989), hsp70 was
not upregulated by E1A, but instead by the
mutant htt in our experiments with E1A-
deficient adenovirus vectors. These results collectively suggest
that hsp70 is another candidate gene that regulates neuron type-
specific cell death.
The first question we asked in the present study was, whether
the upregulation of hsp70 gene expression led to an increase in the
hsp70 protein. Western blot analyses of primary neurons clearly
showed a remarkable increase in the hsp70 protein at a magni-
tude of 8 folds, and the change was observed specifically in the
cerebellar neurons expressingmutant htt (Fig. 2A,B). Although a
similar response was not found in most non-neuronal cell lines,
we found that HeLa cells did show a similar increase of hsp70 by
mutant htt (Fig. 2C). Therefore, we conducted a second experi-
Figure 1. The microarray analyses with three neuron subtypes expressing Atx-1 or htt. A, Cortical neurons (CTX), striatal
neurons (STR), and cerebellar neurons (CBL). The vertical bar of the graph indicates the signal intensities of the spots on the
microarray inmutant polyQ gene expression, and the horizontal bar indicates the signals in normal polyQ gene expression. Green
bars indicate thresholds of threefold. For the generation of probes, primary neurons were infected with adenovirus vectors of
normal or mutant polyQ disease genes (htt or Atx-1) and mRNA was prepared at 2 d after infection. B, A comparison of genes
whose expression was changed more than threefold. Left panels show a comparison between Atx-1 and htt in each neuron
subtype. Middle panels are analyzed with different types of polyQ genes. The top right panel includes vulnerable combinations,
and the bottom right panel indicates resistant combinations.
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ment usingHeLa cells in parallel with primary neurons to analyze
molecular mechanisms relevant to hsp70 upregulation.
Despite the dramatic increases in hsp70, other heat shock pro-
teins such as hsp40, hsp84, hsp105, and MRJ, did not change
remarkably in our microarray and Western blot analyses (data
not shown). Microarray analysis did not detect a change in hsc70
(cellular cognate form) in any of the six combinations of neurons
and polyQ genes (data not shown). Although hsp27 increased
remarkably in microarray analyses, the protein increase was not
confirmed by Western blots (data not shown). Therefore, up-
regulation of hsp70 by the mutant htt represents a highly specific
change in cerebellar neurons.
Next, we examined the relationship between the mutant htt
aggregation and hsp70 upregulation (Fig. 3A). The CAG53b an-
tibody, which reacts with hard aggregates more strongly than
preaggregates of mutant polyQ (Tagawa et al., 2004), revealed
that hsp70 increases in primary cerebellar neurons possessing
inclusion bodies of mutant htt (Fig. 3A). As has been reported
previously in other studies (Jana et al., 2000; Krobitsch and
Lindquist, 2000;Muchowski et al., 2000;Wyttenbach et al., 2000;
Waelter et al., 2001a; Wyttenbach et al., 2001; Zhou et al., 2001),
the hsp70 protein is partially colocalized with the mutant htt in
inclusion bodies (Fig. 3A). To confirm that mutant htt and mu-
tant Atx-1 were expressed at equivalent levels in cerebellar neu-
rons, we further performed immunocytochemistrywithCAG53b
and 1C2 antibodies (Fig. 3B). Although these antibodies detected
different distributions and different aggregation states of themu-
tant proteins, total expression levels were collectively almost
equivalent between mutant htt and Atx-1 (Fig. 3B).
We also examinedwhether hsp70 increases in the granule cells
of human patient brains by immunohistochemical analyses (Fig.
4). We found that the signal intensities of hsp70 in the granular
layer were significantly increased in HD patients in comparison
to the control (Fig. 4A–D). However, the signals were not
changed in the molecular layer and in Purkinje cells (Fig. 4E,F).
In the cerebrum, the cortical neurons possessed similar levels of
hsp70 in both the patients and the controls (Fig. 4G,H).
Furthermore, we performed Western blotting with human
brain tissue specimens.We detected an obvious increase of hsp70
protein in the cerebellar cortex of the mild HD cases (grade 1–3)
in comparison to the Parkinson’s disease brains, but not in the
frontal lobe cortex of the cerebrum (Fig. 5A). Interestingly, the
change was diminished in advanced HD patients (grade 4 or 5).
To rule out postmortem changes of hsp70 protein, we performed
similar experiments with the R6/2mutant htt-transgenicmice. In
this case, we detected an upregulation of hsp70 both in the pr-
esymptomaticmice at 4 weeks and in the symptomaticmice at 14
weeks (Fig. 5B). These results support the significance of the
upregulation of hsp70 in the human HD pathology.
Hsp70 expression levels regulate susceptibility of primary
neurons to mutant htt
Hsp70 attenuates neurotoxicity in different model systems of
polyQ diseases in vivo (Cummings et al., 1998, 2001; Chai et al.,
1999; Warrick et al., 1999; Zhou et al., 2001; Adachi et al., 2003;
Wacker et al., 2004). To address whether upregulation of hsp70
also diminishes htt(exon1)111Q-induced neurotoxicity in cere-
bellar neurons, RNAi experiments were performed to selectively
downregulate hsp70. We found that the siRNA/Hsp70#1 down-
regulated the hsp70 protein level to 50% in cerebellar neurons
(Fig. 6A, left). When the cell death was quantified by a trypan
blue assay, the decrease of hsp70 enhanced the toxicity of mutant
htt in cerebellar granule cells (Fig. 6A, right). In contrast, the
siRNA/Hsp70#2, which did not reduce hsp70 levels, had no effect
on cell death by mutant htt (Fig. 6A). Simultaneously to this
exploration, we examined whether hsp70 expression increases
the resistance of cortical neurons to mutant htt. As expected,
cortical neurons that overexpress hsp70 became resistant to mu-
tant htt (Fig. 6B). These results collectively suggest that the ex-
pression levels of hsp70 critically regulate the susceptibility of
primary neurons to mutant htt.
To test whether the hsp70 induction affects the formation of
inclusion bodies, we stained the htt(exon1)111Q-expressing
neurons after a siRNA/Hsp70#1 treatment with N-18 and 1C2
antibodies. The RNAi treatment decreased the percentage of
N-18 stained inclusion-positive cells from13.9 to 10.5%,whereas
the signals from 1C2 staining became stronger by suppression of
hsp70 (data not shown).
Hsp70 upregulation in granule cells is not mediated by HSF1
To investigate the transcriptional regulation of hsp70 in response
to mutant htt, we firstly inquired into the involvement of heat
shock factor 1 (HSF1), a well known transcription factor regulat-
Figure 2. Hsp70 protein is induced by mutant htt specifically in cerebellar neurons. A, Western
blot analyses showed that theexpressionofhtt(exon1)111Q remarkably increased thehsp70protein
in cerebellar neurons (CBL),whereas htt(exon1)20Qor empty virus vectors did not affect hsp70.Mu-
tant htt did not affect expression of hsp70 in cortical neurons (CTX) or in striatal neurons (data not
shown). Days indicate the duration between adenovirus infection and sampling.B, HeLa cells show
the remarkable response of hsp70 to mutant htt similar to that in cerebellar neurons. Normal and
mutant Atx-1 (Atx1–30 andAtx1–82) did not affect hsp70 inHeLa cells.
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ing heat shock proteins.HSF1 plays a central role in the transcrip-
tional regulation of multiple heat shock proteins (Pirkkala et al.,
2001). In response to various stimuli such as heat, oxidants, and
heavy metals, the phosphorylation and translocation of HSF1
into the nucleus are induced (Pirkkala et al.,
2001). Phosphorylated HSF1 binds to heat-
shock elements locating upstream to heat
shock protein genes, and upregulates tran-
scription from those genes. There is no
doubt that HSF1 generally activates tran-
scription from the hsp70 gene. However it
does not mean that endogenous HSF1 is ac-
tually activated in the HD pathology.
Therefore, in this study, we examined
whether mutant htt expression activates
HSF1 in granule cells. Unexpectedly, im-
munocytochemistry revealed that mu-
tant htt expression does not induce
translocation of HSF1 to the nucleus
(Fig. 7A), although it is indispensable for
the activation of HSF1. Consistently, the
Western blotting findings did not show a
shift of HSF1 from the cytoplasmic frac-
tion to the nuclear fraction (supplemen-
tal Fig. 3, available at www.jneurosci.org
as supplemental material). Furthermore,
the phosphorylation of Ser230 of HSF1,
which has a positive effect on the trans-
activating capacity of HSF1, was not in-
duced by mutant htt expression in cere-
bellar neurons (data not shown).
Collectively, these results clearly deny
the activation of HSF1 by mutant htt in
granule cells. Although the results were
unexpected, this conclusion matched
well with the microarray result that
other heat shock protein genes regulated
by HSF1 were not changed in granule
cells by mutant htt, except in the case of
hsp27 (Fig. 2, supplemental Tables 1, 2,
available at www.jneurosci.org as sup-
plemental material).
CBF and p53 are involved in the
upregulation of hsp70 in response to
mutant htt
The gene expression of hsp70 is also regu-
lated by p53 (Agoff et al., 1993). p53 func-
tionsas a repressive cofactor to the transcrip-
tion factor, CBF that upregulates hsp70 via
two CCAAT boxes in the promoter region
(Agoff et al., 1993). We suspected that CBF
and p53 might similarly regulate transcrip-
tional activation in response to the mutant
htt. We first examined the correlation
whetherCBFupregulateshsp70 inHeLacells
by immunocytochemsitry (Fig. 7B). A posi-
tive relationship was clearly observed be-
tween CBF and hsp70 expression, when the
CBF-FLAG was transiently expressed in
HeLa cells (Fig. 7B). In contrast, p53 signals
generally tend to be low in aggregation-
positive cells, especially in cells possessing
perinuclear ring-like aggregates (supplemental Fig. 4, available at
www.jneurosci.org as supplementalmaterial). These results support
our assumption that CBF and p53 regulate hsp70.
Next, using a CAT assay, we investigated whether CBF and
Figure 3. The induction levels of hsp70 correlate with expression levels of mutant htt in cerebellar neurons. Normal and
mutant polyQ disease proteins were expressed in cerebellar neurons by adenovirus vectors. Four days after infection, neurons
were stained with the CAG53b antibody (Scherzinger et al., 1997) that detects both Atx-1 and htt (Tagawa et al., 2004). Neurons
expressing mutant htt at high levels showed a remarkable increase of hsp70. The expression levels of htt and Atx-1 are shown in
supplemental Figures 1 and 2 (available at www.jneurosci.org as supplemental material).
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p53 directly regulate the hsp70 gene in
HeLa cells. Because hsp70 was similarly
upregulated inHeLa cells and granule cells
in response to the mutant htt (Fig. 2), we
analyzed transcriptional regulation with
HeLa cells into which we can transfect
plasmids more efficiently than into pri-
mary neurons. A CAT reporter plasmid
containing the human hsp70 gene pro-
moter was first constructed and then mul-
tiple deletion plasmids lacking one or two
CCAAT boxes were made from it (sup-
plemental Fig. 5A, available at www.
jneurosci.org as supplemental material).
We performed CAT assays with these re-
porter plasmids in HeLa cells, and found
that both of the two CCAAT boxes con-
tributed to basal transcription of the hsp70
promoter (supplemental Fig. 5B, available
at www.jneurosci.org as supplementalma-
terial). In addition, the deletion of the two
CCAATboxes cancelled transactivation by
mutant htt (supplemental Fig. 5B, avail-
able at www.jneurosci.org as supplemental
material). Moreover, we confirmed that
CBF and p53 regulated transcription of the
human hsp70 promoter in a positive and
negative manner, respectively (supplemen-
tal Fig. 5C, available at www.jneurosci.org as
supplemental material). The effects elicited
by CBF and p53 were lost through the dele-
tionof theCCAATboxes fromthepromoter
(data not shown). Collectively, the results of
the CAT assay support the notion that CBF
and p53 cooperatively regulate the gene ex-
pression of hsp70 through the above-men-
tioned cis-elements.
Basal expression and induction of p53
varies the response of hsp70
If this is the case, then why do cortical and
cerebellar neurons show different effects on hsp70 by the mutant
htt? To answer the question, we performed CAT assays using
primary cerebellar neurons (Fig. 8). Although transfection effi-
ciency was very low, we could confirm in cerebellar neurons that
CBF upregulated and p53 downregulated transcription through
the hsp70 gene promoter (Fig. 8A). Mutant htt stimulated tran-
scription through the hsp70 gene promoter (Fig. 8A, lane 1 vs 5).
The effects of CBF and mutant htt were completely lost by delet-
ing the CCAAT boxes from the promoter (Fig. 8A, lanes 4, 8)
indicating that the transcriptional regulation was similar to that
in HeLa cells. The coexpression of p53 repressed transactivation
by CBF in granule cells (Fig. 8B). However, transfection of
siRNA, although repressing p53, enhanced it slightly (Fig. 8B). In
addition, we found in ChIP assays that mutant htt expression
induced the binding of CBF to the hsp70 gene promoter, both in
cortical neurons and granule cells (Fig. 8C). Meanwhile, the atti-
tude of p53 was different in cortical and in cerebellar neurons
(Fig. 8C). p53 binds to the promoter in response to mutant htt
expression in cortical neurons but not in cerebellar neurons (Fig.
8C). Furthermore, we confirmed that the siRNA-mediated sup-
pression of CBF inhibited the mutant htt-induced upregulation
of hsp70 (Fig. 8D). Collectively, these results suggest that the
interaction of p53 to the transcription machinery on the hsp70
gene promoter inhibits the expression of hsp70 in cortical neu-
rons, but the inhibition does not occur in cerebellar neurons.
To analyze the background of the different responses of p53 to
mutant htt, we performed an immunocytochemical analysis with
cerebellar and cortical neurons expressing the mutant htt (Fig.
9A). First, we found that the basal expression level of p53 was
lower in cerebellar (CBL) neurons than in cortical (CTX) neu-
rons (Fig. 9A, CBL-AxCA vs CTX-AxCA). In addition, most of
the cerebellar neurons possessing inclusion bodies did not show
the increase of p53. Only 2%of inclusion-positive cerebellar neu-
rons showed an increase of p53 (p53-positive htt nuclear inclu-
sion body) (Fig. 9), despite the fact thatmost of the p53 seemed to
be sequestered into inclusion bodies. In contrast, in cortical neu-
rons, p53 increased not only in inclusion body-positive cells, but
also in inclusion body-negative cells (Fig. 9A, CTX). Western
blotting with primary neurons also confirmed a far lower expres-
sion level of p53 in cerebellar neurons than in cortical neurons
(Fig. 9B). In addition, Western blotting with mutant htt trans-
genic mice and age-matched control mice brains revealed a sim-
ilarly low expression of p53 in the cerebellum (Fig. 9C). Interest-
ingly, induction of p53 was also low in granule cells treated with
Figure 4. Hsp70 is increased in the cerebellar granule cells of human HD patients. A–C, In the brains of HD patients, signal
intensities of hsp70 are remarkably higher in the granular layer (gl) of the cerebellum than inwhitematter (w).D, In contrast, the
signal intensities of hsp70 of granular cell layers are lower than those of white matter in control brains. The right panel shows a
comparison of the signal intensities in granular layers between HD and control brains. *p 0.01, Student’s t test. E, F, High
magnification confirmed the induction of hsp70 in the granule cells of the HD brain (gl in E vs F ). Meanwhile, Purkinje cells (E and
F, arrows) show very low signals of hsp70 both in the HD and control brains (E, F ). Basket cells surrounding Purkinje cells show
especially high signals (arrowheads). G,H, Signal intensities of hsp70 of the cortical neurons in the cerebral cortex (arrows) were
closely similar between HD and the control. Scale bars: 10m. Error bars indicate SEM.
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bleomycin (supplemental Fig. 6, available at www.jneurosci.org
as supplemental material), thus suggesting that the insensitivity
of p53 is a characteristic of granule cells.
The interaction of p53 with mutant htt has been reported
previously by other researchers (Steffan et al., 2000; Bae et al.,
2005). The interaction by itself and/or resultant sequestration
into inclusion bodies may repress the transcriptional activity
of p53.We have reported previously that the aggregationman-
ners of mutant htt are different among neuronal subtypes
(Tagawa et al., 2004). Mutant htt forms various inclusion bod-
ies in the morphology, and nuclear inclusion bodies increase
chronologically in all neuronal subtypes. The frequency of
each type of inclusion body and the ratio of nuclear inclusion
bodies are clearly different among neurons (Tagawa et al.,
2004). In granule cells, nuclear inclusions emerge more
promptly and more frequently than in other types of neurons
(Tagawa et al., 2004). The prompt formation of nuclear inclu-
sions in granule cells might be thus considered to inactivate
p53 more than in other neurons. To support this idea, we
found that the ratio of mutant htt-induced cell death was
lower in p53 aggregation-positive cortical neurons than in
aggregation-negative (diffusely stained) cortical neurons
(supplemental Fig. 7, available at www.jneurosci.org as sup-
plemental material).
To summarize the results of the promoter assays and the im-
munohistochemical analyses, different levels of p53 under mu-
tant htt expression may explain the different responses of hsp70
observed in cortical and cerebellar neurons (Fig. 10).
Discussion
A novel mechanism underlying neuron
subtype-selective pathology
This study originated with our question into why specific sub-
types of neurons are vulnerable in neurodegenerative disorders,
and why such vulnerable subtypes are different in various disor-
ders. To answer these questions, we performed microarray anal-
yses of three types of primary neurons expressing normal/mutant
htt or Atx-1, and found that hsp70 regulated neuron subtype-
specific vulnerability in the HD pathology. Looking at changes in
expression, we found selective upregulation of hsp70 in cerebellar
neurons by mutant htt. The upregulation was induced in neither
Figure 5. Western blot confirmation of the upregulation of hsp70 in the cerebellum of HD
modelmice and human HD patients.Western blotting performedwith human HD brains (mild,
grade 1–3; severe, grade 4, 5) andwith PD brains (mild, Yahr’s grade 1–3; severe, Yahr’s grade
4, 5) confirmed HD-specific upregulation of hsp70 protein in the cerebellum. No upregulation
was observed in the cerebral cortex (CTX). For the Western blots, surface tissues (1 mm
thick) were prepared under themicroscope from the cerebellar hemisphere cortex (CBL) or
the prefrontal lobe cortex (CTX) that had been preserved at80°C after autopsy. Western
blotting was performed with R6/2 mutant htt-transgenic mice at different ages. The
upregulation of hsp70 was observed in the cerebellum of both the presymptomatic mice
[4 weeks (w)] and symptomatic mice (14 w).
Figure 6. The expression levels of hsp70 affect the vulnerability of primary neurons to mu-
tant htt. A, When hsp70 upregulation by mutant htt is diminished by siRNA, granule cells
become vulnerable to mutant htt. *p 0.01, Student’s t test. Two types of siRNA (Hsp70#1,
Hsp70#2) were transfected into in cerebellar neurons to repress upregulation of hsp70 by mu-
tant htt. Hsp70#1 reducedhsp70up to50%(theeffectwas limitedbecauseof a low transfection
efficiency of primary neurons with lipofection), whereas Hsp70#2 was not effective. B, Coex-
pression of hsp70with mutant htt in cortical neurons reduced cell death when compared with
the single expression of mutant htt (*p 0.01, Student’s t test). Independent experiments
were performed 20 times. Error bars indicate SEM.
Tagawa et al. • Hsp70 Regulates Selective Neuronal Death J. Neurosci., January 24, 2007 • 27(4):868–880 • 875
of the other neuronal subtypes by mutant
htt, nor in granule cells by mutant Atx-1.
This indicates that upregulation is highly
specific to the expression of mutant htt in
granule cells. Although a certain culturing
condition might affect the expression lev-
els of hsp70, we repeated the primary cul-
ture of neurons 30 times for both the
microarray andWestern blot analyses and
the results were highly reproducible. Fur-
thermore, other heat shock factors such as
hsp40, hsp84, hsp105, andMRJ were not
changed in our microarray and Western
blot analyses (data not shown), ruling out
the possibility that a certain stress during
the culture caused upregulation of hsp70.
Therefore, the selective upregulation of
hsp70 could be a novel mechanism under-
lying the selective neurodegeneration, dis-
tinct from the mechanisms reported pre-
viously (Waragai et al., 1999; Li et al., 2000;
Humbert et al., 2002; Okazawa et al., 2002;
Rangone et al., 2004;Warby et al., 2005). It
is of note that all of these mechanisms re-
ported previously accelerate the pathology,
and no protective factor has been implicated
in the selective pathology. Therefore, this
study constitutes the first research to suggest
the novel concept that neuroprotective fac-
tor(s) might also be involved in neuronal
subtype-selective pathology.
P53 regulates transcriptional induction
of hsp70 in cerebellar neurons
Unexpectedly, our results exclude the pos-
sibility thatHSF1 upregulates hsp70 in cer-
ebellar neurons expressing mutant htt.
Retrospectively, however, these results
seem natural, as HSF1-regulated heat
shock proteins such as hsp40, hsp84,
hsp105, and MRJ were not changed in
our microarray and immunoblot analyses
(datanot shown). Instead,we found that p53,which represses trans-
activationbyCBFas anegative cofactor (Agoff et al., 1993), regulates
hsp70 in cerebellar neurons.
Both in HeLa cells and in primary cerebellar neurons, CBF
activated and p53 repressed transcription of the hsp70 gene (Fig.
7B, 8). CBF bound to the promoter in response to the expression
of mutant htt (Fig. 8). In cortical neurons, basal and mutant
htt-induced expression levels of p53 were high, whereas the
levels of p53 were low in cerebellar neurons. Therefore, induc-
tion of hsp70 by CBF is not disturbed by p53 in cerebellar
neurons (Fig. 10).
Various studies have suggested the involvement of p53 family
proteins in the polyQ pathology (Hoshino et al., 2006). p53 me-
diates cellular dysfunction and behavioral abnormalities in HD
animal models (Bae et al., 2005). p53 binds to the upstream and
intron regions of the human htt gene and upregulates the gene
expression of htt in cortical and striatal neurons (Feng et al.,
2006). These findings suggest the direct toxic roles of p53 in the
HD the pathology. In contrast, our study shows the indirect role
of p53 to inhibit the cell-protective response of hsp70 at the tran-
scription level (supplemental Fig. 8, available at www.jneurosci.org
as supplemental material). The indirect role of p53 also seems
consistentwith the protective function of inclusion bodies (Arrasate
et al., 2004;Tagawaet al., 2004), considering the sequestrationofp53
into the inclusion bodies (Steffan et al., 2000).
Relationship amongmutant htt, hsp70, and p53 in
the pathology
Mutant polyQ proteins seem to induce the conformational
change of a wide range of proteins and thereby affect the physio-
logical metabolism of neurons (Gidalevitz et al., 2006). Hsp70
could antagonize such a general effect on cellular proteins. Actu-
ally, a number of studies support the concept that hsp70 protects
neurons in the polyQ pathology (Cummings et al., 1998, 2001;
Chai et al., 1999;Warrick et al., 1999; Zhou et al., 2001; Adachi et
al., 2003), and the Muchowski group previously revealed that
hsp70 partitions monomers of mutant huntingtin to prevent the
formation of spherical or annular oligomers (Wacker et al.,
2004). Therefore, the upregulation of hsp70 in the nuclei of gran-
ule cells is considered to reduce the toxicity of mutant htt oli-
gomers and to recover the physiological functions of various nu-
clear proteins.
Figure 7. HSF1 is not activated by the expression of mutant htt. A, Immunohistochemistry revealed that HSF1 was not
increased in cerebellar neurons expressing mutant htt. The signal intensities of HSF1 were similar in neurons expressing mutant
htt (arrows) and in neurons without the immunostaining of mutant htt (arrowheads). Notably, HSF1 remained in the cytoplasm
ofmutant htt-expressing neurons, and no translocation of HSF1 to the nucleuswas observed.B, CBF induces expression of hsp70.
Transiently expressed FLAG-CBF was detected by an anti-FLAG antibody. The anti-hsp70 (K20) antibody detected induction of
hsp70 in HeLa cells overexpressing CBF. RC, Relief contrast.
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This study shows that p53 negatively regulates hsp70 gene
expression as a repressive cotranscription factor of CBF (Fig. 8).
Meanwhile, hsp70 is known to inactivate p53 by dissociating the
p53 tetramer in the nucleus and by participating in the cytoplas-
mic sequestration or degradation of p53
(Zylicz et al., 2001). Therefore, hsp70 and
p53 seem to form a negative-feedback
loop, suppressing each other. However,
Feng et al. (2006) reported induction of htt
by p53. Bae et al. (2005) and the present
study have shown induction of p53 bymu-
tant htt. Thus, htt and p53 seem to consti-
tute a positive-feedback loop. The expres-
sion levels of p53 might classify neurons
into a vulnerable group or a resistant
group through the two functionally oppo-
site feedback loops (supplemental Fig. 8,
available at www.jneurosci.org as supple-
mental material).
Other candidate genes in the
polyQ pathologies
In microarray analyses, we found some
other genes that may be relevant to the
polyQ pathologies (Fig. 1B), although we
did not investigate them in this study. Such
genes include Omi, Cbl-2, and RoXaN,
which are downregulated in striatal neu-
rons specifically by mutant htt. Omi is a
mitochondrial serine protease normally
present in the intermembrane space ofmi-
tochondria, whose mutation has been
shown to cause degeneration of striatal
neurons and motor neurons (Jones et al.,
2003). The mutation seems to activate mi-
tochondrial permeability transition pores
andmake neurons vulnerable to proapop-
totic agents (Jones et al., 2003). Further-
more,Omimutations are suggested to link
to sporadic Parkinson’s disease (Strauss et
al., 2005), whereas patients of familial PD
(PARK3) did not carry any mutation in
exons or around splicing junctions (Jones
et al., 2003). Therefore, Omi could be a
candidate gene involved in the polyQ pa-
thology. Cbl-b is an E3 ubiquitin ligase that
mono-ubiquitinates membrane receptors
for recycling through clathrin vesicles. It is
important to note thatHIP1 (huntingtin in-
teracting protein 1) is involved in the sub-
membrane molecular structure of clathrin-
coated vesicles (Engqvist-Goldstein et al.,
1999; Kim et al., 1999; Metzler et al., 2001;
Rao et al., 2001; Waelter et al., 2001a,b;
Legendre-Guillemin et al., 2005). The sub-
strates of Cbl-b include the epidermal
growth factor receptor, colony-stimulating
factor 1 receptor, hepatocyte growth factor
receptor/Met, and soon(PeschardandPark,
2003). The third gene, RoXaN, which is
downregulatedbymutant htt in striatal neu-
rons, is a novel cellular protein that forms a
ternarycomplexwith the initiation factor4G
and rotavirus protein neuroendocrine-specific protein 3 (Vitour et
al., 2004). However, the physiological functions of RoXaN remain
mostly unknown. The pathophysiological function of hnRNPH,
which is upregulated in resistant neurons in two polyQ pathologies,
Figure8. Mutanthttregulatestheexpressionofhsp70 incerebellarneuronsthroughCBFandCCAATboxes.A,Basaltranscriptionfrom
thehsp70promoterwas increased to threefoldbyexpressionofmutanthtt (lane1vs5). CBFadditionally enhances transcription (lanes2,
6) whereas p53 represses basal transcription (lanes 3, 7). The effects of exogenously expressed CBF and p53 were similar regardless of
mutant htt (lanes 1–3, 5–7). When the two CCAAT boxes were deleted, transcriptional activation of the hsp70 gene promoter was
completely lost (lane 8), indicating thatmutant htt upregulates hsp70 gene expression through the two CCAAT boxes. The lower graph
shows a quantitative analysis of CAT activities. Asterisks indicate statistically significant differences according to Student’s t test ( p
0.05). B, p53 expression levels critically affect transactivation by CBF through the hsp70 promoter. The coexpression of p53 represses
transactivation by CBF, whereas reduction of p53with siRNA enhances transactivation by CBF. Asterisks indicates statistically significant
differencesaccordingtoStudent’s t test ( p0.05).C, TheChIPassayshowsthatmutanthtt inducesthe interactionofCBFwiththehsp70
promoter.p53bindstothepromoteronly incorticalneuronsexpressingmutanthtt.Althoughp53 isexpressed inprimarycorticalneurons
in the absence ofmutant htt (Fig. 9), p53does not bind to the promoter. Thismeans that the binding of p53 to thehsp70genepromoter
depends on CBF because the promoter possesses no p53binding consensus sequence.D, Themutant htt-induced upregulation of hsp70
was repressed in HeLa cells by cotransfection of CBF-specific siRNA but not by nonspecific siRNA. The effect of siRNA on the CBF protein
levelswas assayedwith coexpressed FLAG-CBF by the transfection of pCI-FLAG-CBF. Error bars indicate SEM.
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should also be analyzed. Our group is cur-
rently investigating the pathological func-
tions of these candidate molecules by ex-
pressing them in primary neurons with
mutant polyQ proteins (Inagaki, Qi, and
Okazawa, unpublished observation).
A comparison with other studies of gene
expression profiling in HD models
Several groups have reported a transcrip-
tome analysis of the HD pathology. Luthi-
Carter et al. (2002a,b) analyzed two types
of HDmodel mice (R6/2 and N171–82Q)
with gene chips and found that multiple
genes in various signaling pathways are di-
minished in both models. Chan et al.
(2002) compared gene expression profiles
among four transgenic mice expressing
short peptides or the full-length protein of
mutant htt, and reported their expression
profiles to be different. Strand et al. (2005)
applied this technique to skeletal muscle
samples of HD patients to search for bi-
omarkers. Sipione et al. (2002) investi-
gated early the transcriptional profiles in
huntingtin-inducible striatal cells. The re-
sults from these experiments, however, are
not completely consistent, suggesting that
microarray results, even from repeated ex-
periments, could be modified by various
experimental conditions and therefore
should be considered as initial data pre-
senting candidate genes, but not genuine
pathological participants.
Previously, Hodges et al. (2006) re-
ported a microarray analysis of multiple
brain regions of human HD patients. The
genes selected on the basis of expression
were mostly different between their study
and our own. Several reasons may explain
the differences. First, their group used hu-
man brains containing a large number of
glial cells and vascular cells, whereas our
primary culture contained 1% of astro-
cytes and no vascular cells. Second, we
were able to prepare mRNA at the starting
point of inclusion body formation,
whereas their analysis was performed on
patients at the age of40 years. Most pa-
tients were already symptomatic, suggest-
ing their brain tissue already contained
numerous inclusions. However, our study
could receive the criticism that primary
neurons in vitromight have different char-
acters from those of neurons in vivo. How-
ever, as we have already discussed, the array should be considered
as an initial tool to approach candidates, and confirmation or
selection of the candidates is more important. Hence, this study
shows that hsp70 is indeed changed in patients’ brains in vivo and
that the protective function of hsp70 has been well established
even beyond to our present results. Therefore, it is highly plausi-
ble that cerebellar neuron-specific upregulation of hsp70 contrib-
utes to selective pathologies in HD. Finally, data from multiple
studies should be integrated to uncover the true pathological
transcriptome, because the basic idea is common among the var-
ious studies.
Conclusion
In this study, we identified the novel phenomenon that hsp70 is
upregulated specifically in cerebellar granule cells. In addition, our
findings show that the underlying mechanism might be a neuron
Figure 9. The response of p53 is clearly different in granule cells and cortical neurons. A, The basal level expression of p53 is
higher in cortical neurons (CTX, AxCX) than in granule cells (CBL, AxCA). The expression of mutant htt does not upregulate p53 in
most ofmutant htt-expressing granule cells (CBL, arrowhead). In addition, the inclusion bodies ofmutant htt sequestered p53 are
upregulated in only a small part of granule cells (CBL, arrows). In contrast, most p53 is not sequestered into inclusion bodies in
cortical neurons (CTX, arrowhead). To calculate the percentages of p53-positive and -negative granule cells,100 inclusion
body-positive cells were counted in primary cerebellar neuron. Nuclear inclusion bodieswere detected by the CAG53b antibody in
2% of cerebellar granule cells (top panels), whereas they were very rare among cortical neurons (bottom panels). It is important
to note that inclusion-body formation did not affect p53 foci formation (arrow). Mutant htt was expressed in cerebellar and
cortical neurons by adenovirus vectors (AxCA, htt(exon1)111Q), as described in Materials andMethods. B, Western blotting with
primary neurons confirmed that the expression level of p53 to be far lower in the cerebellar neurons (CBL) than in the cortical
neurons (CTX). C, Western blotting with 4-week-old mutant htt transgenic (Tg) and age-matched control (C) mouse brains
showed p53 to be similarly lower in the cerebellum than in the cerebral cortex.
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subtype-specific response to p53. Themechanistic knowledge could
beuseful for developing anovel therapeutic approachwhere vulner-
able neurons are changed to resistant neurons in theHDpathology.
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